Orchard Therapeutics PLC Sponsored ADR Research and Development Expenses 2019-2023 | ORTX
Orchard Therapeutics PLC Sponsored ADR research and development expenses from 2019 to 2023. Research and development expenses can be defined as an expense arising from studies and product development processes.
| Orchard Therapeutics PLC Sponsored ADR Annual Research and Development Expenses (Millions of US $) |
|
|---|---|
| 2022 | $94 |
| 2021 | $87 |
| 2020 | $94 |
| 2019 | $117 |
| 2018 | $205 |
| 2017 | $33 |
| 2016 | $16 |
| Orchard Therapeutics PLC Sponsored ADR Quarterly Research and Development Expenses (Millions of US $) |
|
|---|---|
| 2023-09-30 | $15 |
| 2023-06-30 | $17 |
| 2023-03-31 | $16 |
| 2022-12-31 | $26 |
| 2022-09-30 | $18 |
| 2022-06-30 | $22 |
| 2022-03-31 | $28 |
| 2021-12-31 | $23 |
| 2021-09-30 | $21 |
| 2021-06-30 | $22 |
| 2021-03-31 | $21 |
| 2020-12-31 | $23 |
| 2020-09-30 | $15 |
| 2020-06-30 | $32 |
| 2020-03-31 | $25 |
| 2019-12-31 | $31 |
| 2019-09-30 | $28 |
| 2019-06-30 | $40 |
| 2019-03-31 | $17 |
| 2018-12-31 | $17 |
| 2018-09-30 | $28 |
| 2018-06-30 | $151 |
| 2018-03-31 | $9 |
